496 related articles for article (PubMed ID: 14755720)
1. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications.
Farrer M; Kachergus J; Forno L; Lincoln S; Wang DS; Hulihan M; Maraganore D; Gwinn-Hardy K; Wszolek Z; Dickson D; Langston JW
Ann Neurol; 2004 Feb; 55(2):174-9. PubMed ID: 14755720
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein missense and multiplication mutations in autosomal dominant Parkinson's disease.
Hope AD; Myhre R; Kachergus J; Lincoln S; Bisceglio G; Hulihan M; Farrer MJ
Neurosci Lett; 2004 Aug; 367(1):97-100. PubMed ID: 15308306
[TBL] [Abstract][Full Text] [Related]
3. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
Zarranz JJ; Alegre J; Gómez-Esteban JC; Lezcano E; Ros R; Ampuero I; Vidal L; Hoenicka J; Rodriguez O; Atarés B; Llorens V; Gomez Tortosa E; del Ser T; Muñoz DG; de Yebenes JG
Ann Neurol; 2004 Feb; 55(2):164-73. PubMed ID: 14755719
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.
Fuchs J; Nilsson C; Kachergus J; Munz M; Larsson EM; Schüle B; Langston JW; Middleton FA; Ross OA; Hulihan M; Gasser T; Farrer MJ
Neurology; 2007 Mar; 68(12):916-22. PubMed ID: 17251522
[TBL] [Abstract][Full Text] [Related]
5. Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease.
Langston JW; Sastry S; Chan P; Forno LS; Bolin LM; Di Monte DA
Exp Neurol; 1998 Dec; 154(2):684-90. PubMed ID: 9878203
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation.
Spira PJ; Sharpe DM; Halliday G; Cavanagh J; Nicholson GA
Ann Neurol; 2001 Mar; 49(3):313-9. PubMed ID: 11261505
[TBL] [Abstract][Full Text] [Related]
7. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.
Nishioka K; Hayashi S; Farrer MJ; Singleton AB; Yoshino H; Imai H; Kitami T; Sato K; Kuroda R; Tomiyama H; Mizoguchi K; Murata M; Toda T; Imoto I; Inazawa J; Mizuno Y; Hattori N
Ann Neurol; 2006 Feb; 59(2):298-309. PubMed ID: 16358335
[TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein mRNA expression in sporadic Parkinson's disease.
Tan EK; Chandran VR; Fook-Chong S; Shen H; Yew K; Teoh ML; Yuen Y; Zhao Y
Mov Disord; 2005 May; 20(5):620-3. PubMed ID: 15719423
[TBL] [Abstract][Full Text] [Related]
9. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
[TBL] [Abstract][Full Text] [Related]
10. Failure to find alpha-synuclein gene dosage changes in 190 patients with familial Parkinson disease.
Gispert S; Trenkwalder C; Mota-Vieira L; Kostic V; Auburger G
Arch Neurol; 2005 Jan; 62(1):96-8. PubMed ID: 15642855
[TBL] [Abstract][Full Text] [Related]
11. alpha-Synuclein locus triplication causes Parkinson's disease.
Singleton AB; Farrer M; Johnson J; Singleton A; Hague S; Kachergus J; Hulihan M; Peuralinna T; Dutra A; Nussbaum R; Lincoln S; Crawley A; Hanson M; Maraganore D; Adler C; Cookson MR; Muenter M; Baptista M; Miller D; Blancato J; Hardy J; Gwinn-Hardy K
Science; 2003 Oct; 302(5646):841. PubMed ID: 14593171
[No Abstract] [Full Text] [Related]
12. Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia.
Ikeuchi T; Kakita A; Shiga A; Kasuga K; Kaneko H; Tan CF; Idezuka J; Wakabayashi K; Onodera O; Iwatsubo T; Nishizawa M; Takahashi H; Ishikawa A
Arch Neurol; 2008 Apr; 65(4):514-9. PubMed ID: 18413475
[TBL] [Abstract][Full Text] [Related]
13. Genomic organization and expression of the human beta-synuclein gene (SNCB).
Lavedan C; Leroy E; Torres R; Dehejia A; Dutra A; Buchholtz S; Nussbaum RL; Polymeropoulos MH
Genomics; 1998 Nov; 54(1):173-5. PubMed ID: 9806846
[TBL] [Abstract][Full Text] [Related]
14. Experimental models of Parkinson's disease.
Beal MF
Nat Rev Neurosci; 2001 May; 2(5):325-34. PubMed ID: 11331916
[TBL] [Abstract][Full Text] [Related]
15. Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred.
Duda JE; Giasson BI; Mabon ME; Miller DC; Golbe LI; Lee VM; Trojanowski JQ
Acta Neuropathol; 2002 Jul; 104(1):7-11. PubMed ID: 12070658
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of alpha-synuclein pathology in the cerebellum of Guamanian patients with parkinsonism-dementia complex.
Sebeo J; Hof PR; Perl DP
Acta Neuropathol; 2004 Jun; 107(6):497-503. PubMed ID: 15024581
[TBL] [Abstract][Full Text] [Related]
17. Abnormal migration of human wild-type alpha-synuclein upon gel electrophoresis.
Moussa CE; Wersinger C; Rusnak M; Tomita Y; Sidhu A
Neurosci Lett; 2004 Nov; 371(2-3):239-43. PubMed ID: 15519765
[TBL] [Abstract][Full Text] [Related]
18. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
Kotzbauer PT; Giasson BI; Kravitz AV; Golbe LI; Mark MH; Trojanowski JQ; Lee VM
Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854
[TBL] [Abstract][Full Text] [Related]
19. Gene dosage and pathogenesis of Parkinson's disease.
Eriksen JL; Przedborski S; Petrucelli L
Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms.
Ibáñez P; Lesage S; Janin S; Lohmann E; Durif F; Destée A; Bonnet AM; Brefel-Courbon C; Heath S; Zelenika D; Agid Y; Dürr A; Brice A;
Arch Neurol; 2009 Jan; 66(1):102-8. PubMed ID: 19139307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
